Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Portadown, United Kingdom Clinical Trials

A listing of Portadown, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI

The purpose of this study is to evaluate the efficacy and safety of LCZ696 titrated to a target dose of 200 mg twice daily, compared to ramipril titrated to a target dose of 5 mg twice daily, in addition to conventional post-AMI treatment, in reducing the occurrence of composite endpoint ...

Phase

2.01 miles

Learn More »

A Randomized Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients

The purpose of this study is to demonstrate the superiority of LCZ696 over individualized medical therapy for comorbidities in reducing N-terminal pro-brain natriuretic peptide (NT-proBNP) and improving HF symptoms and functional capacity in patients with heart failure with preserved ejection fraction (HFpEF).

Phase

2.01 miles

Learn More »

SPRITE - A Feasibility and Pilot Study

METHODS - The development of the novel home-based rehabilitation programme, adapted from the "Heart Manual", will follow the guidelines of the MRC for developing complex health service interventions. The steps of the guidelines include: 1) exploring relevant theory; 2) modelling the preliminary intervention by selecting the main components based on ...

Phase N/A

2.01 miles

Learn More »

USG PECS vs LIA for Breast Cancer Surgery

Breast cancer is the commonest cancer in UK for which women undergo surgery. Pain relief for breast surgery may be either opioid/morphine based or regional or local anesthetic technique based. Both have specific advantages and disadvantages. Regional anesthesia is known to suppress the stress response to surgery by blocking noxious ...

Phase N/A

2.01 miles

Learn More »

Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS

This is an event driven study to reach statistical power given all other assumptions. Subjects will visit the clinic 1 month after randomization and at regular intervals thereafter. Additionally, for any subject prematurely discontinuing study medication, assessments will be conducted every 6 months for the collection of study endpoints. Those ...

Phase

2.16 miles

Learn More »